Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4
Author:
Affiliation:
1. Department of Obstetrics and Gynaecology, Campus Bio Medico, University of Rome, Rome, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2017.1266263
Reference118 articles.
1. Serum HE4 as a prognostic marker in endometrial cancer — A population based study
2. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
3. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer
4. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding
5. HE4 as a biomarker for ovarian and endometrial cancer management
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer;Biomedicines;2023-10-01
2. ROMA Index Is an Effective Predictor for Advanced Endometrial Cancer before Surgery;Disease Markers;2022-12-23
3. lncRNA NBAT1 Inhibits Cell Metastasis and Promotes Apoptosis in Endometrial Cancer by Sponging miR-21-5p to Regulate PTEN;Computational and Mathematical Methods in Medicine;2022-07-20
4. Predictive Value of Serum Cytokeratin 19 Level for the Feasibility of Conserving Ovaries in Endometrial Cancer;Frontiers in Medicine;2021-08-05
5. Endometrial cancer: A systematic review of HE4, REM and REM-B;Clinica Chimica Acta;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3